Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-18
2011-12-13
Chandrakumar, Nizal (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S269700, C546S275400
Reexamination Certificate
active
08076486
ABSTRACT:
The invention provides novel heteroaryl-substituted arylaminopyridine derivative MEK inhibitors of Formula (Ia)Such compounds are MEK inhibitors that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation. Also disclosed is the treatment of a hyperproliferative disease in mammals, and pharmaceutical compositions containing such compounds.
REFERENCES:
patent: WO 00/42029 (2000-07-01), None
patent: WO 00/42029 (2000-07-01), None
patent: WO 02/072571 (2002-09-01), None
patent: WO 2004/024711 (2004-03-01), None
patent: WO 2004/052280 (2004-06-01), None
patent: WO 2004/056789 (2004-07-01), None
patent: WO 2004/056789 (2004-07-01), None
patent: WO 2004091480 (2004-10-01), None
patent: WO 2005/000818 (2005-01-01), None
patent: WO 2005/004818 (2005-01-01), None
patent: WO 2005/051301 (2005-06-01), None
patent: WO 2006045514 (2006-04-01), None
patent: WO 2006/045514 (2006-05-01), None
Chang, et al., “Signal Transduction Mediated by the Ras/Raf/MEK/ERK pathway from Cytokine Receptors to Transcription Factors: Potential Targeting for Therapeutic Intervention,”MTT Leukemia, 17:1263-1293 (2003).
Crews, et al., “The Primary Structure of MEK, a Protein Kinase That Phosphorylates the ERK Gene Product,”Science, 258:478-480 (1992).
Lee, et al., “Regulation of Hepatocyte Growth Factor-Mediated Urokinase Plasminogen Activator Secretion by MEK/ERK Activation in Human Stomach Cancer Cell Lines,”Experimental and Molecular Medicine, 38:27-35 (2006).
Reddy, el al., “Role of MAP Kinase in Tumor Progression and Invasion,”Cancer and Metastasis Reviews, 22:395-403 (2003).
Askew, Jr. Benny C.
Chen Xiaoling
Goutopoulos Andreas
Karra Srinivasa
Yu Henry
Brown Thomas W.
Chandrakumar Nizal
EMD Serono Research Institute
Merck Serono S.A.
LandOfFree
Heteroaryl-substituted arylaminopyridine derivatives as MEK... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl-substituted arylaminopyridine derivatives as MEK..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl-substituted arylaminopyridine derivatives as MEK... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4314732